LINCOLN, Neb., May 01, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced results for the first quarter of 2018.
Digital VOC Platform highlights:
- VOC contract value doubles to $29 million
- Platform accounts for 21% of total first quarter revenue up from 10% year-over-year
- Platform variable direct expense drops in half
- Major back-to-back wins confirm emerging advantage at point of sale
Remarking on Company performance, Michael D. Hays, chief executive officer of National Research Corporation said, “The quarter is less about consolidated performance and all about our unwavering focus in migrating current clients to our digital VOC platform. Early results are ahead of my expectations and our point of sale advantage is becoming confirmed.”
Kevin Karas, chief financial officer commented, “The quarter was noisy driven by unique events including our recapitalization, adoption of the new revenue recognition standard, impact of the 2017 Tax Act and redirection of sales resources to convert existing clients to the digital platform.”
Revenue for the quarter ended March 31, 2018 was $31.0 million, compared to $30.3 million for the same quarter in 2017. Net income for the quarter ended March 31, 2018, was $7.3 million, compared to $6.5 million for the quarter ended March 31, 2017. Diluted earnings per share increased to $0.17 for Class A shares and $1.01 for Class B shares for the quarter ended March 31 2018, from diluted earnings per share of $0.15 for Class A shares and $0.91 for Class B shares for the quarter ended March 31, 2017.
A listen-only simulcast of National Research Corporation’s 2018 first quarter conference call will be available online at http://edge.media-server.com/m6/p/9zmhhi86 on May 2, 2018, beginning at 11:00 a.m. Eastern time. The online replay will follow approximately one hour later and continue for 30 days.
For more than 37 years, National Research Corporation has been a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations in the United States and Canada. The Company’s solutions enable its clients to understand the voice of the customer with greater clarity, immediacy and depth.
This press release includes “forward-looking” statements related to the Company that can generally be identified as describing the Company’s future plans, objectives or goals. Such forward-looking statements are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the factors that could affect the Company’s future results, please see the Company’s filings with the Securities and Exchange Commission.
NATIONAL RESEARCH CORPORATION AND SUBSIDIARY
Unaudited Condensed Consolidated Statements of Income
(In thousands, except per share data)
| Three months ended | |||||||
| March 31, | |||||||
| 2018 | 2017 | ||||||
| Revenue | $ | 31,017 | $ | 30,276 | |||
| Operating expenses: | |||||||
| Direct | 12,909 | 12,500 | |||||
| Selling, general and administrative | 7,867 | 6,686 | |||||
| Depreciation and amortization | 1,283 | 1,106 | |||||
| Total operating expenses | 22,059 | 20,292 | |||||
| Operating income | 8,958 | 9,984 | |||||
| Other income (expense): | |||||||
| Interest income | 45 | 14 | |||||
| Interest expense | (8 | ) | (27 | ) | |||
| Other, net | (28 | ) | 9 | ||||
| Total other income (expense) | 9 | (4 | ) | ||||
| Income before income taxes | 8,967 | 9,980 | |||||
| Provision for income taxes | 1,661 | 3,459 | |||||
| Net income | $ | 7,306 | $ | 6,521 | |||
| Earnings Per Share of Common Stock: | |||||||
| Basic Earnings Per Share: | |||||||
| Class A | $ | 0.17 | $ | 0.15 | |||
| Class B | $ | 1.04 | $ | 0.93 | |||
| Diluted Earnings Per Share: | |||||||
| Class A | $ | 0.17 | $ | 0.15 | |||
| Class B | $ | 1.01 | $ | 0.91 | |||
| Weighted average shares and share equivalents outstanding | |||||||
| Class A - Basic | 20,884 | 20,737 | |||||
| Class B - Basic | 3,527 | 3,513 | |||||
| Class A - Diluted | 21,837 | 21,245 | |||||
| Class B - Diluted | 3,630 | 3,576 | |||||
NATIONAL RESEARCH CORPORATION AND SUBSIDIARY
Unaudited Condensed Consolidated Balance Sheets
(Dollars in thousands, except per share amounts and par value)
| Mar. 31, | Dec. 31, | ||||||
| 2018 | 2017 | ||||||
| ASSETS | |||||||
| Current Assets: | |||||||
| Cash and cash equivalents | $ | 35,478 | $ | 34,733 | |||
| Accounts receivable, net | 14,306 | 14,806 | |||||
| Income taxes receivable | 68 | 375 | |||||
| Other current assets | 2,426 | 2,345 | |||||
| Total Current Assets | 52,278 | 52,259 | |||||
| Property and equipment, net | 12,456 | 12,359 | |||||
| Goodwill | 57,956 | 58,021 | |||||
| Deferred contract costs | 3,571 | -- | |||||
| Other, net | 4,715 | 4,677 | |||||
| Total Assets | $ | 130,976 | $ | 127,316 | |||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
| Current Liabilities: | |||||||
| Accounts payable and accrued expenses | $ | 3,893 | $ | 3,546 | |||
| Deferred revenue | 16,965 | 16,878 | |||||
| Accrued compensation | 3,538 | 6,597 | |||||
| Dividends payable | 4,223 | 4,222 | |||||
| Income taxes payable | 865 | -- | |||||
| Notes payable | -- | | 1,067 | ||||
| Total Current Liabilities | 29,484 | 32,310 | |||||
| Non-Current Liabilities | 6,128 | 4,965 | |||||
| Total Liabilities | 35,612 | 37,275 | |||||
| Shareholders’ Equity: | |||||||
| Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued | |||||||
| Class A Common stock, $0.001 par value; authorized 60,000,000 shares, issued 25,916,792 in 2018 and 25,835,230 in 2017, outstanding 20,988,085 in 2018 and 20,936,703 in 2017 | 26 | 26 | |||||
| Class B Common stock, $0.001 par value; authorized 80,000,000 shares, issued 4,328,552 in 2018 and 4,319,256 in 2017, outstanding 3,540,857 in 2018 and 3,535,238 in 2017 | 4 | 4 | |||||
| Additional paid-in capital | 52,216 | 51,025 | |||||
| Retained earnings | 83,392 | 77,574 | |||||
| Accumulated other comprehensive loss | (2,049 | ) | (1,635 | ) | |||
| Treasury stock | (38,225 | ) | (36,953 | ) | |||
| Total Shareholders’ Equity | 95,364 | 90,041 | |||||
| Total Liabilities and Shareholders’ Equity | $ | 130,976 | $ | 127,316 | |||